Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hartig

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Pharmacological Reviews|June 1, 1994
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)D Hoyer, D E Clarke, J R Fozard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 1999
Messenger RNA editing of the human serotonin 5-HT2C receptorL W Fitzgerald, G Iyer, D S Conklin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclaseN Adham, H T Kao, L E Schecter, et al.
Molecular Pharmacology|April 1, 1994
The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtypeC Forray, J A Bard, J M Wetzel, et al.
The Journal of Pathology|April 1, 2006
Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cellsR Schneider-Stock, D Kuester, O Ullrich, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Synthesis and in vivo characterization of D-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptorsJ R Lever, R F Dannals, A A Wilson, et al.
Brain Research. Molecular Brain Research|April 20, 2001
Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptorS P Ho, L K Takahashi, V Livanov, et al.
Synapse (New York, N.Y.)|January 1, 1987
Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSDD F Wong, J R Lever, P R Hartig, et al.
The EMBO Journal|June 15, 1995
The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variantsC Gerald, N Adham, H T Kao, et al.
Journal of Neurochemistry|April 27, 1999
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist actionL W Fitzgerald, D S Conklin, C M Krause, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Pharmacological Reviews|June 1, 1994
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin)D Hoyer, D E Clarke, J R Fozard, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 1999
Messenger RNA editing of the human serotonin 5-HT2C receptorL W Fitzgerald, G Iyer, D S Conklin, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993
Cloning of another human serotonin receptor (5-HT1F): a fifth 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclaseN Adham, H T Kao, L E Schecter, et al.
Molecular Pharmacology|April 1, 1994
The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtypeC Forray, J A Bard, J M Wetzel, et al.
The Journal of Pathology|April 1, 2006
Close localization of DAP-kinase positive tumour-associated macrophages and apoptotic colorectal cancer cellsR Schneider-Stock, D Kuester, O Ullrich, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Synthesis and in vivo characterization of D-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptorsJ R Lever, R F Dannals, A A Wilson, et al.
Brain Research. Molecular Brain Research|April 20, 2001
Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptorS P Ho, L K Takahashi, V Livanov, et al.
Synapse (New York, N.Y.)|January 1, 1987
Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSDD F Wong, J R Lever, P R Hartig, et al.
The EMBO Journal|June 15, 1995
The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variantsC Gerald, N Adham, H T Kao, et al.
Journal of Neurochemistry|April 27, 1999
High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist actionL W Fitzgerald, D S Conklin, C M Krause, et al.
Pageof 8